Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-07-24 Sale | 2024-07-26 4:20 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 2,813 | $27.76 | $78,089 | 144,926 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 4:19 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 3,456 | $27.76 | $95,939 | 138,160 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 4:17 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 4,015 | $27.76 | $111,456 | 333,394 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:42 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 2,505 | $29.69 | $74,382 | 337,409 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:41 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,044 | $29.69 | $90,386 | 371,359 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:39 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 3,123 | $29.69 | $92,733 | 347,544 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:38 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 2,867 | $29.69 | $85,132 | 443,986 (Direct) | View |
| 2024-07-17 Sale | 2024-07-19 5:36 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 8,685 | $29.69 | $257,888 | 1,023,412 (Direct) | View |
| 2024-07-09 Sale | 2024-07-10 5:07 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 4,747 | $28.06 | $133,201 | 350,667 (Direct) | View |
| 2024-07-09 Sale | 2024-07-10 5:06 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 1,527 | $28.06 | $42,848 | 446,853 (Direct) | View |
| 2024-07-09 Sale | 2024-07-10 5:04 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 4,619 | $28.06 | $129,609 | 1,032,097 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:18 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 4,042 | $29.65 | $119,845 | 355,414 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:15 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 16,163 | $29.65 | $479,233 | 1,036,716 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:14 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 3,247 | $29.65 | $96,274 | 448,380 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:13 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 3,247 | $29.65 | $96,274 | 374,403 (Direct) | View |
| 2024-05-22 Sale | 2024-05-24 4:10 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 3,242 | $29.65 | $96,125 | 339,914 (Direct) | View |
| 2024-04-24 Sale | 2024-04-26 5:22 pm | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 3,261 | $28.9 | $94,243 | 141,616 (Direct) | View |
| 2024-04-24 Sale | 2024-04-26 5:20 pm | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 7,239 | $28.9 | $209,207 | 147,739 (Direct) | View |
| 2024-04-24 Sale | 2024-04-26 5:18 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 3,963 | $28.9 | $114,531 | 343,156 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 6:06 pm | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 9,827 | $29.06 | $285,554 | 347,119 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 6:05 pm | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 8,280 | $29.06 | $240,602 | 377,650 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 6:01 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 12,253 | $29.06 | $356,049 | 359,456 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 5:59 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 10,115 | $29.06 | $293,923 | 451,627 (Direct) | View |
| 2024-04-17 Sale | 2024-04-19 5:57 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 34,079 | $29.06 | $990,269 | 1,052,879 (Direct) | View |
| 2024-04-09 Sale | 2024-04-10 4:18 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 3,689 | $31.18 | $115,023 | 371,709 (Direct) | View |
| 2024-04-09 Sale | 2024-04-10 4:16 pm | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 1,053 | $31.18 | $32,833 | 461,742 (Direct) | View |
| 2024-04-09 Sale | 2024-04-10 4:14 pm | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 4,807 | $31.18 | $149,882 | 1,086,958 (Direct) | View |
| 2024-02-22 Sale | 2024-02-23 4:21 pm | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 2,930 | $36.15 | $105,920 | 320,420 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-02 Option Award | 2024-04-04 4:54 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Fromkin Andrew J. Director | 15,945 | $0 | 104,603 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:50 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Hughes Douglas J. Director | 15,945 | $0 | 129,700 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:48 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | MIGAUSKY GEORGE V Director | 15,945 | $0 | 125,753 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:46 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Pande Atul Director | 15,945 | $0 | 119,103 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:44 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Torti Frank Director | 170,567 | $0 | 685,841 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:39 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Stout Jay S Chief Technology Officer | 123,701 | $0 | 223,701 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:37 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer | 123,701 | $0 | 425,669 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:34 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Macias William L. Chief Medical Officer | 123,701 | $0 | 454,653 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:31 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Geffner Michael Chief Medical Officer | 123,701 | $0 | 213,600 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:29 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Butchko Julia G. Chief Development Officer | 123,701 | $0 | 531,518 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:27 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Barnett Eva Renee Chief Financial Officer | 123,701 | $0 | 444,121 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-04 4:23 pm | N/A 2034-04-02 | Immunovant Inc. | IMVT | Salzmann Peter Chief Executive Officer | 361,201 | $0 | 1,292,432 (Direct) | View |